Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

EEG-based neurofeedback in post-traumatic stress disorder assessed in Sweden

In Sweden, the County Councils are grouped into six healthcare regions to facilitate cooperation and to maintain a high level of advanced medical care. One of them is Västra Götaland County Council with its Health Technology Assessment (HTA) Center, which aimed to work for continuous development of knowledge-based care in the region and ensure that healthcare is supported by science and evaluation. In addition, it should follow up on the development of evidence-based healthcare nationally, and internationally.

On the 16th of April of 2019, Västra Götaland HTA-Centre has published an HTA report for electroencephalography (EEG)-based neurofeedback as a treatment for post-traumatic stress disorder (PTSD). The objective of this HTA was to assess whether EEG-based neurofeedback is an effective treatment for patients with PTSD compared with sham neurofeedback, other therapy or no treatment. Measures of self-harm and suicidal thoughts, PTSD symptoms, level of functioning, and health-related quality of life were considered critical outcomes for decision-making. The degree of sick leave, medication use, complications and patients’ experience of the treatment were deemed to be essential outcomes.

The following conclusions were provided:

  • No study evaluated EEG-based neurofeedback versus sham neurofeedback, and hence a placebo effect cannot be excluded. Based on three small RCTs, with several study limitations and imprecision, it is uncertain whether EEG-based neurofeedback compared with no treatment or standard treatment reduces PTSD symptoms post-treatment in adult patients with PTSD (very low certainty of evidence)
  • It is also uncertain whether EEG-based neurofeedback treatment results in any difference in suicidal thoughts, level of functioning, or medication use compared with no or other treatment (very low certainty of evidence)
  • Health-related quality of life, sick leave, and patients’ experience of treatment were not studied in the RCTs, and information on complications was sparse
  • Equipment costs and training needs for implementation of EEG-based neurofeedback are modest

See the full report in Swedish and English here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.